<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: hepatitis</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Study shows promise for new cancer-stopping therapy</title>
   	 <description>Researchers at Nationwide Children's Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.</description>
     <link>http://www.physorg.com/news163942021.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Jun 2009 12:28:26 EST</pubDate>
	 <guid isPermaLink="false">news163942021</guid>
</item>
<item>
     <title>Subclinical markers predict relapse in juvenile idiopathic arthritis post methotrexate withdrawal</title>
   	 <description>Elevated levels of the inflammatory biomarkers Myeloid Related Protein (MRP*) 8/14 predict an increased risk of relapse following withdrawal of methotrexate (MTX) therapy in children with juvenile idiopathic arthritis (JIA) who have achieved inactive disease status, according to a new study.</description>
     <link>http://www.physorg.com/news163937936.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Jun 2009 11:19:23 EST</pubDate>
	 <guid isPermaLink="false">news163937936</guid>
</item>
<item>
     <title>NEJM study points to new era in hepatitis C treatment</title>
   	 <description>For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.</description>
     <link>http://www.physorg.com/news163418460.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 05 Jun 2009 11:02:04 EST</pubDate>
	 <guid isPermaLink="false">news163418460</guid>
</item>
<item>
     <title>Artificial liver may extend lives</title>
   	 <description>The first artificial organ for liver patients that uses immortalized human liver cells, the Extracorporeal Liver Assist Device, or ELAD(R), is a bedside system that treats blood plasma, metabolizing toxins and synthesizing proteins just like a real liver does.</description>
     <link>http://www.physorg.com/news163163349.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 02 Jun 2009 12:11:49 EST</pubDate>
	 <guid isPermaLink="false">news163163349</guid>
</item>
<item>
     <title>Liver disease 'shrunk' by blood-pressure drug</title>
   	 <description>A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients.</description>
     <link>http://www.physorg.com/news163061294.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 07:48:39 EST</pubDate>
	 <guid isPermaLink="false">news163061294</guid>
</item>
<item>
     <title>Environmental pollution increases the risk of liver disease</title>
   	 <description>A new study is the first to show that there is a previously unrecognized role for environmental pollution in liver disease in the general U.S. adult population. This work builds upon the groups' previous research demonstrating liver disease in highly-exposed chemical workers. The study is being presented during Digestive Disease Week 2009 (DDW), the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.</description>
     <link>http://www.physorg.com/news162815194.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 29 May 2009 11:27:06 EST</pubDate>
	 <guid isPermaLink="false">news162815194</guid>
</item>
<item>
     <title>Some donor factors affect outcomes for HCV-positive liver transplant recipients</title>
   	 <description>Two new studies address donor factors that could affect outcomes for liver transplant recipients, particularly those with chronic hepatitis C (HCV). One found that donor steatosis, or fat in the liver, does not affect liver disease progression or three-year survival in recipients with or without HCV. However, transplants from people higher on the Donor Risk Index did adversely affect the outcomes of HCV-positive recipients more than recipients without HCV.</description>
     <link>http://www.physorg.com/news162740009.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 14:33:52 EST</pubDate>
	 <guid isPermaLink="false">news162740009</guid>
</item>
<item>
     <title>New treatment option for patients with chronic hepatitis C</title>
   	 <description>A new combination therapy of daily consensus interferon (CIFN) and ribavirin is effective for some people with chronic hepatitis C (HCV) who do not respond to standard therapy. The treatment works particularly well in interferon-sensitive patients who have lower fibrosis scores, according to a new study in the June issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news162739824.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 May 2009 14:30:41 EST</pubDate>
	 <guid isPermaLink="false">news162739824</guid>
</item>
<item>
     <title>'Gene silencing' may improve treatment of a deadly complication of liver disease</title>
   	 <description>A technique that `silences,` or turns off, genes shows promise as a potential new treatment for liver fibrosis  - the disease that leads to cirrhosis  - scientists in Tennessee are reporting. Their study is scheduled for the June 1 issue of ACS` Molecular Pharmaceutics. Cirrhosis is the 12th leading cause of death in the United States.</description>
     <link>http://www.physorg.com/news162667470.html</link>
	 <category>Chemistry</category>
	 <pubDate>Wed, 27 May 2009 18:25:02 EST</pubDate>
	 <guid isPermaLink="false">news162667470</guid>
</item>
<item>
     <title>Filling the gap: The importance of Medicaid continuity for former inmates</title>
   	 <description>It is time for states to suspend, rather than terminate, the Medicaid benefits of inmates while they are incarcerated, say correctional health care experts from The Miriam Hospital in a commentary published online by the Journal of General Internal Medicine.</description>
     <link>http://www.physorg.com/news161871212.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 18 May 2009 13:14:00 EST</pubDate>
	 <guid isPermaLink="false">news161871212</guid>
</item>
<item>
     <title>Veterinarians at high risk for viral, bacterial infections from animals</title>
   	 <description>The recent H1N1 influenza epidemic has raised many questions about how animal viruses move to human populations. One potential route is through veterinarians, who, according to a new report by University of Iowa College of Public Health researchers, are at markedly increased risk of infection with zoonotic pathogens -- the viruses and bacteria that can infect both animals and humans.</description>
     <link>http://www.physorg.com/news161606092.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 15 May 2009 11:35:28 EST</pubDate>
	 <guid isPermaLink="false">news161606092</guid>
</item>
<item>
     <title>Immune exhaustion driven by antigen in chronic viral infection</title>
   	 <description>A main reason why viruses such as HIV or hepatitis C persist despite a vigorous initial immune response is exhaustion. The T cells, or white blood cells, fighting a chronic infection eventually wear out.</description>
     <link>http://www.physorg.com/news161454772.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 17:33:37 EST</pubDate>
	 <guid isPermaLink="false">news161454772</guid>
</item>
<item>
     <title>Hyperferritinemia is another surrogate marker of advanced liver disease</title>
   	 <description>High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients . A study in Italy has investigated the link between ferritin and steatosis in a non-obese cohort of non-alcoholic patients. In southern European populations, high ferritin levels, after exclusion of diagnosis of HH, represent a risk factor for steatosis and clinical relevance, being associated with low platelet count.</description>
     <link>http://www.physorg.com/news161443860.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 May 2009 14:31:40 EST</pubDate>
	 <guid isPermaLink="false">news161443860</guid>
</item>
<item>
     <title>Miami VA: Steps taken to prevent contamination</title>
   	 <description>(AP) --  The top Veterans Affairs official in Miami said Tuesday she has taken steps locally to prevent the kind of problems that exposed patients to contaminated medical equipment at VA hospitals in three states.</description>
     <link>http://www.physorg.com/news161364220.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 12 May 2009 16:32:23 EST</pubDate>
	 <guid isPermaLink="false">news161364220</guid>
</item>
<item>
     <title>Visualizing virus replication in three dimensions</title>
   	 <description>Dengue fever is the most common infectious disease transmitted by mosquitoes - some 100 million people around the world are infected. Researchers at the Hygiene Institute at Heidelberg University Hospital were the first to present a three-dimensional model of the location in the human cell where the virus is reproduced.</description>
     <link>http://www.physorg.com/news160921558.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 07 May 2009 13:26:25 EST</pubDate>
	 <guid isPermaLink="false">news160921558</guid>
</item>
<item>
     <title>Parents of internationally adopted children advised to verify children's immunization levels</title>
   	 <description>A study by the division of global child health at Case Western Reserve University School of Medicine cautions adoptive parents not to rely solely on vaccination records when gauging their internationally adopted children's immunizations.</description>
     <link>http://www.physorg.com/news160753073.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 May 2009 14:38:21 EST</pubDate>
	 <guid isPermaLink="false">news160753073</guid>
</item>
<item>
     <title>Novel antibody prevents infection by hepatitis C virus</title>
   	 <description>Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV).  The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model of the disease.</description>
     <link>http://www.physorg.com/news160751183.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 05 May 2009 14:06:44 EST</pubDate>
	 <guid isPermaLink="false">news160751183</guid>
</item>
<item>
     <title>Helping doctors ask about drug, alcohol problems</title>
   	 <description>(AP) --  If more doctors started asking, would more drug and alcohol abusers 'fess up so they could get help?</description>
     <link>http://www.physorg.com/news160675177.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 16:59:57 EST</pubDate>
	 <guid isPermaLink="false">news160675177</guid>
</item>
<item>
     <title>Study: Patients with resolved hepatitis C likely still contagious</title>
   	 <description>Patients with chronic hepatitis C that has been resolved through therapy or immune response may still be able to infect others with the virus. That finding is from a new study in the May issue of Hepatology, a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news160656818.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 04 May 2009 11:53:52 EST</pubDate>
	 <guid isPermaLink="false">news160656818</guid>
</item>
<item>
     <title>Added anti-viral improves response, halves duration of hepatitis C treatment</title>
   	 <description>The addition of the anti-viral drug telaprevir to a standard treatment for hepatitis C can shorten the duration of therapy and increase the number of patients who can be cured of their disease, according to the results of study coordinated by investigators from the Duke Clinical Research Institute (DCRI).</description>
     <link>http://www.physorg.com/news160275409.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 01:57:21 EST</pubDate>
	 <guid isPermaLink="false">news160275409</guid>
</item>
<item>
     <title>Magnitude of dirty VA hospital equipment unknown</title>
   	 <description>(AP) --  Thousands of veterans were at first shocked to learn they should get blood tests for HIV and hepatitis because three hospitals might have treated them with unsterile equipment. Now, just a couple of months after the Department of Veterans Affairs issued the dire warnings, veterans are growing frustrated by the lack of information from the tightlipped federal agency.</description>
     <link>http://www.physorg.com/news159899366.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 25 Apr 2009 17:29:58 EST</pubDate>
	 <guid isPermaLink="false">news159899366</guid>
</item>
<item>
     <title>VA: 3 patients HIV-positive after clinic mistakes</title>
   	 <description>(AP) --  Three patients exposed to contaminated medical equipment at Veterans Affairs hospitals have tested positive for HIV, the agency said Friday.</description>
     <link>http://www.physorg.com/news159344428.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 19 Apr 2009 07:20:54 EST</pubDate>
	 <guid isPermaLink="false">news159344428</guid>
</item>
<item>
     <title>Do patients at risk for B-cell malignancy need antiviral treatment?</title>
   	 <description>Some studies have shown that a relationship of hepatitis C (HCV) infection with type II mixed cryoglobulinemia exists. However the precise mechanism remains unclear.</description>
     <link>http://www.physorg.com/news159023484.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 15 Apr 2009 14:12:02 EST</pubDate>
	 <guid isPermaLink="false">news159023484</guid>
</item>
<item>
     <title>Working to eradicate dengue fever</title>
   	 <description>(PhysOrg.com) -- A research project led by University of Notre Dame biologist Malcolm J. Fraser Jr. may soon lead to the eradication of dengue fever, a mosquito-borne viral disease that annually infects more than 50 million people worldwide.</description>
     <link>http://www.physorg.com/news158860958.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 13 Apr 2009 17:03:37 EST</pubDate>
	 <guid isPermaLink="false">news158860958</guid>
</item>
<item>
     <title>Shared equipment can lead to hepatitis B outbreaks</title>
   	 <description>Patient-to-patient transmission of hepatitis B virus (HBV) can occur as the result of routine clinical practices incorrectly thought to be risk-free. A review of 33 HBV outbreaks, published in the open access journal BMC Medicine, has shown that the most frequent HBV transmission routes are administration of drugs using multi-vial compounds and capillary blood sampling (e.g. for glucose monitoring) using non-disposable devices.</description>
     <link>http://www.physorg.com/news158474856.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 09 Apr 2009 05:48:15 EST</pubDate>
	 <guid isPermaLink="false">news158474856</guid>
</item>
<item>
     <title>NJ doctor in hepatitis B case fights for license</title>
   	 <description>(AP) --  Health inspectors described finding blood on the floor at the office of a New Jersey doctor whom they suspect is linked to a hepatitis B outbreak.</description>
     <link>http://www.physorg.com/news157978582.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 03 Apr 2009 11:57:00 EST</pubDate>
	 <guid isPermaLink="false">news157978582</guid>
</item>
<item>
     <title>64 infected by hepatitis at hospital in China</title>
   	 <description>(AP) --  Police have detained the director of a Chinese hospital where at least 64 people were infected with the potentially deadly liver disease hepatitis C after receiving transfusions from blood collected illegally, state media reported.</description>
     <link>http://www.physorg.com/news157871030.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 02 Apr 2009 06:04:14 EST</pubDate>
	 <guid isPermaLink="false">news157871030</guid>
</item>
<item>
     <title>The immune system's role in hepatitis C recurrence after liver transplantation</title>
   	 <description>A new study pinpoints certain aspects of the immune system that may play a role in the recurrence and progression of hepatitis C virus (HCV) after liver transplantation. The study is in the April issue of Liver Transplantation, a journal published by John Wiley &amp; Sons.</description>
     <link>http://www.physorg.com/news157815630.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Apr 2009 14:40:50 EST</pubDate>
	 <guid isPermaLink="false">news157815630</guid>
</item>
<item>
     <title>New studies examine elimination of hepatitis B and C</title>
   	 <description>Two new studies in the April issue of Hepatology explore the ways that hepatitis B virus (HBV) and hepatitis C virus (HCV) can be cleared from patients' bodies. Hepatology is a journal published by John Wiley &amp; Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).</description>
     <link>http://www.physorg.com/news157809387.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 01 Apr 2009 12:56:47 EST</pubDate>
	 <guid isPermaLink="false">news157809387</guid>
</item>
<item>
     <title>Mutations within a conservative region of HCV affects the therapy</title>
   	 <description>At least 200 million individuals are currently infected with hepatitis C virus (HCV) worldwide. Approximately 30%-50% of patients respond to interferon/ribavirin combination therapy. Response to interferon therapy depends mainly on viral and host genetic factors. The HCV is continually mutating which allows the virus to evade the immune system and overcome interferon treatment. </description>
     <link>http://www.physorg.com/news157632931.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Mar 2009 11:56:25 EST</pubDate>
	 <guid isPermaLink="false">news157632931</guid>
</item>


</channel>
</rss>

